ImStar Announces the Identification of Lead ALS Drug Candidate

ImStar Therapeutics just announced that they have selected IMS-088 as their lead drug candidate for the treatment of ALS. IMS-088 is chemically similar to withaferin A, which is a natural compound isolated from the leaves of the winter cherry plant. The company plans to continue the preclinical development of IMS-088 during 2014, with the goal of taking this drug towards the clinic. ImStar’s Chief Scientific Officer Dr. Jean-Pierre Julien said “we hope to establish IMS-088 as a safe and effective new drug candidate for ALS.”

Click here to read the full story.

Share this: